Bart L.
- Country
- Belgium
- Department
- Ophthalmology
Research Overview
- Safety and Tolerability of Intravitreal SPVN20 Gene Therapy in End-Stage Rod-Cone Dystrophy with Dormant Foveal Cone Photoreceptors
- Safety and Tolerability of Tinlarebant in Subjects with Stargardt Disease: An Open-Label, Single-Arm, 3-Year Extension Study
- Safety and Efficacy of Subretinal Administration of AAVB-039 in Participants with Stargardt Disease (STGD1): A Phase 1/2 Open-Label, Multicenter Study
Data & Insights
Has run more than one trial at 9 of 19 partner sites.
Specializations
Inherited Retinal Disorders
The investigator specializes in treating rare genetic eye conditions, with particular focus on X-linked retinitis pigmentosa, a progressive vision disorder affecting the retina's photoreceptor cells. Their research encompasses innovative therapeutic approaches for preserving and potentially improving visual function in affected individuals.
- RPGR gene mutations
- Progressive vision loss management
- Gene therapy applications
Juvenile Eye Disorders
The investigator demonstrates expertise in treating Stargardt disease, focusing specifically on adolescent patients. Their work involves evaluating innovative treatments to address retinal atrophy and slow disease progression in young patients with this inherited macular degeneration condition.
- Adolescent retinal disorders
- Atrophic lesion management
- Early intervention strategies
Congenital Eye Conditions
The investigator focuses on treating Leber congenital amaurosis, a severe inherited retinal condition. Their expertise extends to evaluating therapeutic interventions for patients with specific genetic mutations, particularly those affecting the CEP290 gene.
- Genetic mutation analysis
- Early-onset vision loss
- Novel therapeutic approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.